Shuna Colville

发表

Genome-wide association analyses identify new risk variants and the genetic architecture of amyotrophic lateral sclerosis

Annelot M. Dekker, Raymond D. Schellevis, P. Visscher, 2016, Nature Genetics.

The Diagnostic Utility of 99mTc-HMPAO SPECT Imaging: A Retrospective Case Series from a Tertiary Referral Early-Onset Cognitive Disorders Clinic

T. Bak, S. Colville, G. Holloway, 2015, Dementia and Geriatric Cognitive Disorders.

The epidemiology of amyotrophic lateral sclerosis (ALS/MND) in people aged 80 or over.

R. Forbes, S. Colville, R. Swingler, 2004, Age and ageing.

Analysis of amyotrophic lateral sclerosis as a multistep process: a population-based modelling study

N. Pearce, A. Al-Chalabi, C. Shaw, 2014, The Lancet Neurology.

The incidence of motor nueron disease in Scotland

R. Forbes, S. Colville, R. Swingler, 2007, Journal of Neurology.

Validation of The Edinburgh cognitive and behavioural ALS screen (ECAS) in behavioural variant frontotemporal dementia and Alzheimer’s disease

T. Bak, S. Abrahams, S. Colville, 2021, International journal of geriatric psychiatry.

C9orf72, age at onset, and ancestry help discriminate behavioral from language variants in FTLD cohorts

Demis A. Kia, O. Andreassen, B. Miller, 2020, Neurology.

Genetic epidemiology of motor neuron disease-associated variants in the Scottish population

D. Goldstein, S. Chandran, T. Aitman, 2017, Neurobiology of Aging.

ALS-specific cognitive and behavior changes associated with advancing disease stage in ALS

A. Al-Chalabi, C. Shaw, O. Hardiman, 2018, Neurology.

Multidimensional apathy in ALS: validation of the Dimensional Apathy Scale

S. Chandran, S. Abrahams, Ratko Radakovic, 2015, Journal of Neurology, Neurosurgery & Psychiatry.

Efficacy of three neuroprotective drugs in secondary progressive multiple sclerosis (MS-SMART): a phase 2b, multiarm, double-blind, randomised placebo-controlled trial

S. Ourselin, F. Barkhof, D. MacManus, 2020, The Lancet Neurology.

Unexpected decline in survival from amyotrophic lateral sclerosis/motor neurone disease

R. Forbes, G. Cran, S. Colville, 2004, Journal of Neurology, Neurosurgery & Psychiatry.

Frequency, timing and outcome of gastrostomy tubes for amyotrophic lateral sclerosis/motor neurone disease

R. Forbes, S. Colville, F. T. I. Group, 2004, Journal of Neurology.

Investigating Domain-Specific Cognitive Impairment Among Patients With Multiple Sclerosis Using Touchscreen Cognitive Testing in Routine Clinical Care

J. Barnett, S. Colville, S. Pal, 2018, Front. Neurol..

The Patient Health Questionnaire (PHQ-9) as a tool to screen for depression in people with multiple sclerosis: a cross-sectional validation study

S. Chandran, S. Colville, P. Macdonald, 2022, BMC Psychology.

Improved PCR based methods for detecting C9orf72 hexanucleotide repeat expansions

S. Chandran, M. Porteous, S. Colville, 2016, Molecular and cellular probes.

Genotype–phenotype characterisation of long survivors with motor neuron disease in Scotland

I. Deary, S. Chandran, J. Prendergast, 2022, Journal of Neurology.

Genetic correlation between amyotrophic lateral sclerosis and schizophrenia

Denis C. Bauer, Annelot M. Dekker, Ashley R. Jones, 2017, Nature Communications.

Genome-wide association analyses identify new risk variants and the genetic architecture of amyotrophic lateral sclerosis

Annelot M. Dekker, Raymond D. Schellevis, Ashley R. Jones, 2016, Nature Genetics.

Molecular genetic analysis of the APEX nuclease gene in amyotrophic lateral sclerosis

C. Hayward, S. Colville, R. Swingler, 1999, Neurology.

Clinical audit research and evaluation of motor neuron disease (CARE-MND): a national electronic platform for prospective, longitudinal monitoring of MND in Scotland

S. Chandran, S. Abrahams, S. Colville, 2019, Amyotrophic lateral sclerosis & frontotemporal degeneration.

Multidimensional apathy in ALS: validation of the Dimensional Apathy Scale

S. Chandran, S. Abrahams, Ratko Radakovic, 2015, Journal of Neurology, Neurosurgery & Psychiatry.

Validation of the Edinburgh Cognitive and Behavioural Amyotrophic Lateral Sclerosis Screen (ECAS): A cognitive tool for motor disorders

S. Colville, J. Newton, Elaine H. Niven, 2015, Amyotrophic lateral sclerosis & frontotemporal degeneration.

The brief Dimensional Apathy Scale: A short clinical assessment of apathy

J. Starr, S. Chandran, S. Abrahams, 2020, The Clinical neuropsychologist.

Improved survival and 30-day mortality after gastrostomy in Scottish motor neurone disease patients: evidence from a national retrospective cohort study using STROBE criteria

S. Chandran, R. Forbes, M. Hair, 2019, Amyotrophic lateral sclerosis & frontotemporal degeneration.

Theme 5 Epidemiology and informatics

A. Al-Chalabi, S. Chandran, L. Ossher, 2018, Amyotrophic lateral sclerosis & frontotemporal degeneration.